Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

PRINCIPLE Collaborative Group, Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, Oliver Van Hecke, Emma Ogburn, Philip H Evans, Nicholas PB Thomas, Mahendra G Patel, Nicholas Berry, Michelle A. Detry, Christina T. Saunders, Mark Fitzgerald, Victoria Harris, Simon de Lusignan, Monique I Andersson, Peter J Barnes, Richard EK Russell, Dan V Nicolau Jr., Sanjay Ramakrishnan, FD Richard Hobbs, Christopher C Butler
doi: https://doi.org/10.1101/2021.04.10.21254672

Data Availability

Data can be shared with qualifying researchers who submit a proposal with a valuable research question as assessed by a committee formed from the TMG including senior statistical and clinical representation. A contract should be signed.

Back to top
Posted April 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
PRINCIPLE Collaborative Group, Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, Oliver Van Hecke, Emma Ogburn, Philip H Evans, Nicholas PB Thomas, Mahendra G Patel, Nicholas Berry, Michelle A. Detry, Christina T. Saunders, Mark Fitzgerald, Victoria Harris, Simon de Lusignan, Monique I Andersson, Peter J Barnes, Richard EK Russell, Dan V Nicolau Jr., Sanjay Ramakrishnan, FD Richard Hobbs, Christopher C Butler
medRxiv 2021.04.10.21254672; doi: https://doi.org/10.1101/2021.04.10.21254672
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area